Germany’s healthcare market is No. 1 in Europe by market volume, number of patients, medical technology manufacturers, and healthcare providers.
Healthcare spending in Germany exceeded €1 Billion per day in 2017, not including expenditure for wellness and fitness. The market has grown at a rate of 3.8% over the past 10 years. With more than 7.3 million employees and exports in excess of €126 billion, healthcare is one of the largest economic sectors in Germany.
Germany achieves almost universal health insurance coverage
Health insurance coverage is mandatory in Germany. Insurance premiums are shared by employers and employees. The vast majority of the population is enrolled in public health insurance plans. About 10% choose private providers. Both publicly and privately insured can choose their provider. Currently, there are 112 public and 44 private health insurance companies operating in Germany (2017).
More than 1,900 hospitals with nearly 500,000 beds operate in Germany – not including rehabilitation or elderly care facilities. The overall number of medical hospitals is declining as smaller general hospitals close or merge with other hospitals to increase efficiency.
Key Data about German Hospitals
Medical staff (full time)
Average length of stay
Source: Destatis 2018
The share of privately operated hospitals continues to rise
Every year companies participate in thousands of research projects with other partners from industry and scientific institutions, emphasizing Germany’s reputation as a leading environment for healthcare and life sciences. Along the entire value chain – from R&D through scale-up and production to sales and marketing – Germany is known for its outstanding capabilities, resources, and infrastructure.
Germany is home to more than 30 specialized cluster networks focusing on medical technology. Dedicated cluster management teams help obtain funding for joint R&D projects, provide shared facilities, and organize educational training programs for their members.
Germany’s “BioRegions” are regional initiatives for the advancement of modern biotechnology. Over the past three decades, these biotechnology clusters have developed to become Europe’s leading R&D hubs. Each region specializes in particular areas and facilitates collaboration between universities, R&D institutes, and private sector companies.
All rights reserved. Any reproduction in whole or part only with express written permission. All efforts are made to ensure integrity of the content, however we are not liable for any mistakes that may occur.
Promoted by Federal Ministry for Economic Affairs and Energy in accordance with a German Parliament resolution.